• Explore /
  • Poster
  • / Association of intravenous (IV) and intramuscular (IM) pegaspargase (PEG) administration with rate of adverse events (AE) in standard risk (SR) Acute Lymphoblastic Leukemia (ALL) Children’s Oncology Group (COG) trials.

Association of intravenous (IV) and intramuscular (IM) pegaspargase (PEG) administration with rate of adverse events (AE) in standard risk (SR) Acute Lymphoblastic Leukemia (ALL) Children’s Oncology Group (COG) trials.

Abstract Poster

Authors

null

Kelly W. Maloney

Children's Hosp Colorado, Aurora, CO

Kelly W. Maloney , Anne L. Angiolillo , Reuven J. Schore , Meenakshi Devidas , Xiaomin Lu , Cindy Wang , Alison M. Friedmann , Leonard A. Mattano Jr., Mignon L. Loh , Elizabeth A. Raetz , Linda C. Stork , Naomi J. Winick , Stephen Hunger , William L. Carroll

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Leukemia/Lymphoma

Clinical Trial Registration Number

NCT00103285

Citation

J Clin Oncol 33, 2015 (suppl; abstr 10035)

DOI

10.1200/jco.2015.33.15_suppl.10035

Abstract #

10035

Poster Bd #

105

Abstract Disclosures

Similar Posters

First Author: Abdul Hamid Bazarbachi

First Author: Thomas Alexander

First Author: Julio C. Barredo

First Author: Nina S. Kadan-Lottick